This after RETHINK had learned of a study which showed that anti-depressants don’t have any clinically significant effect in most cases 
Rethink’s Paul Corry said:
“This study shows just how vital it is that NHS spending starts to match up with NICE guidelines. The doctors, the patients and campaigners like us have been telling government for years – spend NHS money on talking therapies and don’t just pour it into drugs. Some people do benefit from anti-depressants but they want talking therapies too. We need to get well-trained therapists ready to start delivering the services people need to get better."
“It is great news that there is going to be more cash for talking therapies but we do need to make sure that talking therapies are available to everyone who wants them, that includes people with severe mental illness, not just mild to moderate depression."
“Rethink and the University of York are launching a brand new service with Stoke Primary Care Trust that will see access to psychological therapies increased right across the area. This exciting initiative, the Healthy Minds Network, will finally enable GP’s to give their patients the services they know will benefit them.”
1 Kirsch, Deacon, Huedo-Medina, Scoboria, Moore and Johnson (2008) Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration PLoS Med 5(2): e45. Doi:10.1371/journal.pmed.00050045
Rethink is a campaigning membership charity working with people with severe mental illness, their carers, families and friends through a network of mutual support groups around the country.
Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING